About MSCR
MSCR is a company founded in 2009. The company has 51 employees as of March 22, 2024. MSCR offers products and services including Clinical Trials and Pre-Clinical Testing.
- Employees 51 as on 22 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Ms Clinical Research Pvt. Ltd
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$3.41 M (USD)21.12as on Mar 31, 2023
-
Net Profit
$1.01 M (USD)4.74as on Mar 31, 2023
-
EBITDA
$1.69 M (USD)28.14as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
51
as on Mar 22, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MSCR
MSCR offers a comprehensive portfolio of products and services, including Clinical Trials and Pre-Clinical Testing.
Clinical trials are conducted to substantiate claims in pharmaceuticals and consumer care under expert supervision.
Pre-clinical tests are performed to evaluate product safety and efficacy using methods like microbiology and stability testing.
Funding Insights of MSCR
Detailed funding history for MSCR
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MSCR
Investment portfolio details for MSCR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MSCR
Detailed financials for MSCR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mscr Comparisons
Peer comparison for MSCR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MSCR
Detailed competitors of MSCR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mscr
Complete news archive for MSCR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MSCR
MSCR was founded in 2009.
As of Mar 22, 2024, the latest employee count at MSCR is 51.
Annual revenue of MSCR is $3.41M as on Mar 31, 2023.
MSCR is recognized as a full-service institute that provides clinical and pre-clinical studies for pharmaceuticals, cosmetics, and consumer products. Services are offered to assess safety, efficacy, and tolerability, meeting worldwide compliance standards. Operations are established across facilities in Bangalore, India, with a focus on dermatology and consumer care research. Studies are designed to deliver high-performance data efficiently, supporting product development from inception to completion, while navigating global guidelines.
MSCR offers Clinical Trials and Pre-Clinical Testing.